GAMBARAN HEMOGLOBIN DAN NEUTROFIL PASIEN KEMOTERAPI KANKER PAYUDARA DI ONKOLOGI CENTER RSUD Dr. SOETOMO SURABAYA

HEMOGLOBIN AND NEUTROPHIL OF BREAST CANCER CHEMOTHERAPYPATIENTS AT THE ONCOLOGY CENTER OF Dr. SOETOMO HOSPITAL, SURABAYA

Authors

  • Arie Rachmaningtyas RSUD Dr. Soetomo, Surabaya, Jawa Timur, Indonesia
  • Titik Sundari Universitas Maarif Hasyim Latif
  • Yenny Puspa Rini Universitas Maarif Hasyim Latif
  • Christina Destri Wiwis Wijayanti Universitas Maarif Hasyim Latif

Keywords:

breast cancer, neutrophils, hemoglobin

Abstract

Breast cancer management is chemotherapy. One of the negative impacts of chemotherapy is affecting hemoglobin and neutrophils. This study aims to determine the description of Hemoglobin levels and Neutrophil counts in breast cancer patients undergoing chemotherapy stage 1 (early) and stage 6 (late) at the Oncology Center of Dr. Soetomo Hospital, Surabaya. This study is an observational study with a retrospective design. The sample in this study was some breast cancer patients undergoing chemotherapy stage 1 (early) and 6 (late) at the Oncology Center of Dr. Soetomo Hospital, Surabaya, which was taken as many as 25 people by purposive sampling. Purposive sampling. The study was conducted in the Oncology Center laboratory of Dr. Soetomo Hospital, Surabaya. This study was conducted from October to December 2022. The results of the study showed that breast cancer patients undergoing stage 1 chemotherapy mostly had normal hemoglobin as many as 13 people (52%) with an average Hb level of ± 12.34 g / dL and normal neutrophils as many as 23 people (92%) with an average neutrophil level of ± 4412 cells / µL. In stage 6 chemotherapy, most had low hemoglobin as many as 13 people (52%) with an average Hb level of ± 11.78 g / dL and normal neutrophils as many as 24 people (96%) with an average number of neutrophils of 4202.68 cells / µL.

References

Bellanger, M., Zeinomar, N., Tehranifar, P., & Terry, M. B. (2018). Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? Journal of Global Oncology, 2018(4), 1–16. https://doi.org/10.1200/JGO.17.00207

Budiana, I. N. G., & Febiani, M. (2017). Febrile Neutropenia pada Pasien Pascakemoterapi. Indonesian Journal of Cancer, 11(2), 77–82

Dewi, N. S., Yusmawan, W., & Budiarti, R. (2020). Kejadian Mielosupresi Pada Penderita Kanker Kepala Dan Leher Yang Mendapat Kemoterapi Cisplatin Dan Carboplatin Di RSUP Dr. Kariadi Semarang. Medica Hospitalia?: Journal of Clinical Medicine, 7(1), 34–40. https://doi.org/10.36408/mhjcm.v7i1.425

Febriani, A., & Rahmawati, Y. (2019). Efek Samping Hematologi Akibat Kemoterapi dan Tatalaksananya. Jurnal Respirasi, 5(1), 22. https://doi.org/10.20473/jr.v5-i.1.2019.22-28

Gupta, A. (2019). Management of Chemotherapy Induced Neutropenia – an Unmet Clinical Need. American Journal of Biomedical Science & Research, 4(5), 313–318. https://doi.org/10.34297/ajbsr.2019.04.000823

Hart, L., Ogbonnaya, A., Boykin, K., Deyoung, K., Bailey, R., Heritage, T., Lopez-Gonzalez, L., Huang, H., & Gordan, L. (2023). Burden of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer: A retrospective study from community oncology practices. Cancer Medicine, 12(8), 10020–10030. https://doi.org/10.1002/cam4.5738

Hidayati, A. O., & Arifah, S. (2020). Faktor Kejadian Anemia pada Pasien Kanker yang Mendapat Radioterapi dan atau Kemoterapi. Jurnal Kesehatan, 11(1), 29. https://doi.org/10.26630/jk.v11il.1629

Hima, N. A., Andrajati, R., & Radji, M. (2021). Kejadian Demam Neutropenia pada Pasien Kanker Payudara setelah Menerima Regimen Kemoterapi TAC-G-CSF dan FAC di RSUP Dr. Hasan Sadikin Bandung. Indonesian Journal of Clinical Pharmacy, 10(1), 1. https://doi.org/10.15416/ijcp.2021.10.1.1

Indrasari, Z. (2019). Gambaran Kadar Hemoglobin Pada Penderita Ca Mammae Yang Menjalani Kemoterapi. Repository Institut Ilmu Kesehatan BW Kediri

Ridley, D. M., Dawkins, F., & Perlin, E. (1994). Erythropoietin: a review. Journal of the National Medical Association, 86(2), 129–135.

Shang, C., & Xu, D. (2022). Epidemiology of Breast Cancer. Oncologie, 24(4), 649–663. https://doi.org/10.32604/oncologie.2022.027640

Smolarz, B., Zadro?na Nowak, A., & Romanowicz, H. (2022). Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers, 14(10), 1–27. https://doi.org/10.3390/cancers14102569

Stephenson, J. R., Axelrod, A. A., McLeod, D, L., Shreeve, M. M. (1971). Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc. Natl Acad Sci USA. 1971(68), 1542-1546

Sudiasta, D. G., Yanti, N. L. G. P., & Citrawati, N. K. (2022). Overview of the Quality of Life of Breast Cancer Patients Undergoing Chemotherapy During the COVID-19 Pandemic. Jurnal Keperawatan Dan Fisioterapi (Jkf), 4(2), 260–267. https://doi.org/10.35451/jkf.v4i2.986

Wahyuningsih, R., Kurniawat, D. S., Army, A. N., & Kusmiyati. (2018). Pengalaman dan Harapan Pasien Kanker terhadap Pelayanan Keperawatan untuk Perbaikan Kondisi Layak Kemoterapi di RSUD. Dr. Moewardi Solo. Jurnal Medika Moewardi, 7(1), 1–39.

Published

2024-09-30